KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

West Pharmaceutical Services (WST) Non-Current Deferred Tax Liability (2016 - 2025)

West Pharmaceutical Services' Non-Current Deferred Tax Liability history spans 17 years, with the latest figure at $22.8 million for Q3 2025.

  • For Q3 2025, Non-Current Deferred Tax Liability rose 142.55% year-over-year to $22.8 million; the TTM value through Sep 2025 reached $22.8 million, up 142.55%, while the annual FY2024 figure was $88.3 million, 595.28% up from the prior year.
  • Non-Current Deferred Tax Liability for Q3 2025 was $22.8 million at West Pharmaceutical Services, down from $23.0 million in the prior quarter.
  • Across five years, Non-Current Deferred Tax Liability topped out at $88.3 million in Q4 2024 and bottomed at $1.2 million in Q2 2022.
  • The 5-year median for Non-Current Deferred Tax Liability is $13.7 million (2024), against an average of $17.2 million.
  • The largest annual shift saw Non-Current Deferred Tax Liability tumbled 90.16% in 2022 before it soared 1183.33% in 2023.
  • A 5-year view of Non-Current Deferred Tax Liability shows it stood at $4.9 million in 2021, then surged by 191.84% to $14.3 million in 2022, then dropped by 11.19% to $12.7 million in 2023, then soared by 595.28% to $88.3 million in 2024, then crashed by 74.18% to $22.8 million in 2025.
  • Per Business Quant, the three most recent readings for WST's Non-Current Deferred Tax Liability are $22.8 million (Q3 2025), $23.0 million (Q2 2025), and $21.3 million (Q1 2025).